TLSA — Tiziana Life Sciences Share News
0.000.00%
- $137.84m
- $134.28m
U.S. STOCKS ON THE MOVE-Chevron Corp, Goldman Sachs, Inari Medical
U.S. STOCKS ON THE MOVE-Asana, Build-A-Bear, Pilgrim's Pride
Tiziana jumps as intranasal spray well-tolerated in multiple sclerosis patient
Brief: Tiziana Announces Positive Clinical Data From A Secondary Progressive Multiple Sclerosis Patient Treated For Six Months With Intranasally Administered Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody
Brief: Tiziana Announces Submission Of Amendment To Investigational New Drug Application To Advance Oral Foralumab
Brief: Tiziana Life Sciences Announces Death Of Director
RCS - Tiziana Life Science - Tiziana Life Sciences Announces Death of Director
RCS - Tiziana Life Science - TLSA Enrolls Second Patient in Ongoing SPMS Trial
RCS - Tiziana Life Science - Information Regarding Migration of UK Shares
US STOCKS-Stocks rebound in late-day rally on Wall Street
Brief: Tiziana Life Sciences PLC Files For Mixed Shelf Of Upto $250 Million - SEC Filing
Tiziana Life Sciences: Rises on plans to list asset as separate company
U.S. STOCKS ON THE MOVE-MICT, Seanergy Maritime, Kohl's Corp
U.S. STOCKS ON THE MOVE-MICT, Seanergy Maritime, iMedia Brands
U.S. STOCKS ON THE MOVE-Seanergy Maritime, Tesla, iMedia Brands
Tiziana Life Sciences: Surges on patent win for Crohn's disease treatment
Brief: Tiziana Life Sciences Develops Investigational New Technology To Treat Covid-19 Infections
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:40 AM
Brief: Tiziana Life Sciences PLC Files For Mixed Shelf Of Up To $75 Mln